Tevogen Total Stockholder Equity from 2010 to 2024
| TVGNW Stock | 0.05 0 5.63% |
Total Stockholder Equity | First Reported 2010-12-31 | Previous Quarter -695.8 K | Current Value -661 K | Quarterly Volatility 92.2 M |
Check Tevogen Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tevogen Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 160.5 K, Interest Expense of 227.9 K or Selling General Administrative of 1.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Tevogen financial statements analysis is a perfect complement when working with Tevogen Bio Valuation or Volatility modules.
Tevogen |
Latest Tevogen Bio's Total Stockholder Equity Growth Pattern
Below is the plot of the Total Stockholder Equity of Tevogen Bio Holdings over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Tevogen Bio's Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tevogen Bio's overall financial position and show how it may be relating to other accounts over time.
| Total Stockholder Equity | 10 Years Trend |
|
Total Stockholder Equity |
| Timeline |
Tevogen Total Stockholder Equity Regression Statistics
| Arithmetic Mean | 9,524,085 | |
| Geometric Mean | 13,188,652 | |
| Coefficient Of Variation | 967.71 | |
| Mean Deviation | 44,340,876 | |
| Median | (16,488,548) | |
| Standard Deviation | 92,165,200 | |
| Sample Variance | 8494.4T | |
| Range | 358.6M | |
| R-Value | 0.35 | |
| Mean Square Error | 8050.7T | |
| R-Squared | 0.12 | |
| Significance | 0.21 | |
| Slope | 7,137,126 | |
| Total Sum of Squares | 118921.9T |
Tevogen Total Stockholder Equity History
About Tevogen Bio Financial Statements
Tevogen Bio investors use historical fundamental indicators, such as Tevogen Bio's Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Tevogen Bio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Stockholder Equity | -695.8 K | -661 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Tevogen Stock Analysis
When running Tevogen Bio's price analysis, check to measure Tevogen Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tevogen Bio is operating at the current time. Most of Tevogen Bio's value examination focuses on studying past and present price action to predict the probability of Tevogen Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tevogen Bio's price. Additionally, you may evaluate how the addition of Tevogen Bio to your portfolios can decrease your overall portfolio volatility.